The Egyptian Journal of Internal Medicine

Table 10 Comparison between pretreatment and 12 weeks after EOT Angiopoietin-2 levels in patients with and without fibrosis regression

From: Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs

		Group		T-test
		Regression	Non-regression	t	P-value
Ang-2 before treatment	Range	240–1080	260–960	−4.102	<0.001*
Ang-2 before treatment	Mean ±SD	391.667±184.112	700.000±263.944	−4.102	<0.001*
Ang-2 12 weeks after treatment	Range	120–1000	110–940	−3.554	0.001*
Ang-2 12 weeks after treatment	Mean ±SD	322.333±203.888	638.000±340.353	−3.554	0.001*
Differences	Mean ±SD	69.333±63.893	62.000±102.285
Paired test	P-value	<0.001*	0.088

*significant

Back to article page